Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Genetic Diversity and Evolution

The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses

M. Linster, E. J. A. Schrauwen, S. van der Vliet, D. F. Burke, P. Lexmond, T. M. Bestebroer, D. J. Smith, S. Herfst, B. F. Koel, R. A. M. Fouchier
Adolfo García-Sastre, Editor
M. Linster
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
bProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Linster
E. J. A. Schrauwen
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
cAvans University of Applied Science, Breda, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. van der Vliet
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. F. Burke
dCenter for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Lexmond
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. M. Bestebroer
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. J. Smith
dCenter for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Herfst
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Herfst
B. F. Koel
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
eDepartment of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B. F. Koel
R. A. M. Fouchier
aDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adolfo García-Sastre
Icahn School of Medicine at Mount Sinai
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.01907-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Maximum likelihood phylogenetic tree based on HA1 amino acid sequences of human A/H2N2 viruses. Virus isolates used for antigenic characterization are highlighted in red.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Antigenic map of human A/H2N2 influenza viruses as measured in HI assays with ferret postinfection antisera. Circles indicate the position of viruses, squares represent two ferret antisera raised against each of the viruses A/Japan/305/57, A/Singapore/1/57, A/Netherlands/K1/63, A/England/1/66, A/Tokyo/3/67, and A/Netherlands/B1/68. The underlying grid depicts the scale of antigenic difference between the viruses, with each square representing one antigenic unit or a 2-fold difference in HI titer. Years of isolation of the A/H2N2 virus isolates are indicated, ranging from 1957 (red) to 1968 (blue).

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Summary of substitutions responsible for antigenic differences between NL/M1/57 and NL/B1/68. Antigenic maps showing the antigenic change caused by individual amino acid substitutions introduced into NL/M1/57 (A) or NL/B1/68 (B) and combinations of mutations introduced into NL/M1/57 (C) or NL/B1/68 (D). Viruses are shown as circles of different colors, with a diamond indicating the mutant virus with the largest antigenic distance to the corresponding wild-type strain. Sera are indicated as open squares. The underlying map of wild-type viruses from Fig. 2 is shown in gray, and its positioning is kept constant. The arrows indicate the antigenic distance of a double mutant that spans a long distance between the earliest and latest isolates of A/H2N2. Structure of an HA trimer (E) with individual monomers in shades of gray, the RBS in yellow, and mutations near the RBS with a measurable effect on antigenicity in orange. The two mutations with the biggest combined effect in panel C are colored in red (T128D and N139K).

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Rates of genetic and antigenic evolution of A/H2N2 and A/H3N2 virus during 12 years of circulation in humans. Genetic (A) and antigenic (B) distances of the A/H2N2 (red squares) and A/H3N2 (blue circles) viruses from the first human virus isolates in 1957 (A/Netherlands/M1/1957) and 1968 (A/Bilthoven/16190/1968). Rates are derived from the slope of the best-fit regression line.

Tables

  • Figures
  • TABLE 1

    Hemagglutination inhibition titers for wild-type viruses toward A/H2N2 postinfection ferret antiseraa

    Virus isolateTiter toward ferret postinfection antiserum
    JP/305/57SP/1/57NL/K1/63EN/1/66TY/3/67NL/B1/68
    A/NETHERLANDS/M1/57 [NL/M1/57]2,5601,6001,28032040160
    A/NETHERLANDS/M2/57 [NL/M2/57]9601,6009602404080
    A/SINGAPORE/1/57 [SP/1/57]1,6001,9201,2801603560
    A/NETHERLANDS/M1/58 [NL/M1/58]9609609601603060
    A/NETHERLANDS/N1/59 [NL/N1/59]1,9201,9201,920800240240
    A/NETHERLANDS/H1/60 [NL/H1/60]1,9201,6002,560480120200
    A/NETHERLANDS/67/63 [NL/67/63]5601,2804,480560240800
    A/NETHERLANDS/K1/63 [NL/K1/63]1,6001,1205,760960200800
    A/ENGLAND/12/64 [EN/12/64]602402,2402,8803201,120
    A/SYDNEY/2/64 [SY/2/64]48080048020060160
    A/TAIWAN/1/64 [TA/1/64]803201,1201,9203201,120
    A/MOSCOW/56/65 [MW/56/65]5602402,5604802401,280
    A/ENGLAND/1/66 [EN/1/66]6403203,8406,4003202,240
    A/ENGLAND/10/67 [EN/10/67]1,1203202,5608002401,120
    A/TOKYO/3/67 [TY/3/63]8080160320960320
    A/NETHERLANDS/61/68 [NL/61/68]3201601,1202,240160800
    A/NETHERLANDS/B1/68 [NL/B1/68]2080960960320 2 ,880
    A/NETHERLANDS/B2/68 [NL/B2/68]5060320640640640
    • ↵a One serum per isolate was selected to represent the two individual ferret sera since variation in HI titers between repeat sera was negligible. Viruses emphasized in Fig. 3 are in bold and homologous HI titers are underlined.

  • TABLE 2

    Hemagglutination inhibition titers for mutant viruses toward A/H2N2 postinfection ferret antiseraa

    Virus isolateTiter toward ferret postinfection antiserum
    JP/305/57SP/1/57NL/K1/63EN/1/66TY/3/67NL/B1/68
    NL/M1/57_T126E1,6001,44064032080560
    NL/M1/57_T128D1,60096064028080640
    NL/M1/57_R132K2,2401,28064080080320
    NL/M1/57_N139K1601,1206401,92080640
    NL/M1/57_S154P1,9201,2801,280560360280
    NL/M1/57_T184A1,6001,9201,12032020160
    NL/M1/57_T188A1,2801,6001,92048020160
    NL/B1/68_E126T40806409601601,280
    NL/B1/68_D128T1,1202401,4402,2401602,240
    NL/B1/68_K139N4001606403203202,240
    NL/B1/68_P154S201606408003203,200
    NL/B1/68_A184T401204806401602,560
    NL/B1/68_A188T201001603202401,920
    NL/M1/57_T126EN139K5606406401,9201601,920
    NL/M1/57_T128DN139K806406401,1201602,240
    NL/M1/57_T126ET128DN139K1006403208001402,880
    NL/M1/57_T126ET128DR132KN139K1605602808001601,920
    NL/M1/57_T126ET128DN139KS154PT184AT188A803209608001603,200
    NL/M1/57_T126ET128DR132KN139KS154PT184AT188A803206408001602,560
    NL/B1/68_E126TK139N160320480320160640
    NL/B1/68_D128TK139N3204801,280320160640
    NL/B1/68_E126TD128T808096064080640
    NL/B1/68_E126TD128TK139N9604802,240640160640
    NL/B1/68_E126TD128TK139NK132R6404002,24032060320
    NL/B1/68_E126TD128TK139NP154SA184TA188T960560480280160100
    NL/B1/68_E126TD128TR132KK139NP154SA184TA188T640480640605040
    • ↵a Viruses emphasized in Fig. 3 are in bold.

PreviousNext
Back to top
Download PDF
Citation Tools
The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
M. Linster, E. J. A. Schrauwen, S. van der Vliet, D. F. Burke, P. Lexmond, T. M. Bestebroer, D. J. Smith, S. Herfst, B. F. Koel, R. A. M. Fouchier
Journal of Virology Apr 2019, 93 (8) e01907-18; DOI: 10.1128/JVI.01907-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
M. Linster, E. J. A. Schrauwen, S. van der Vliet, D. F. Burke, P. Lexmond, T. M. Bestebroer, D. J. Smith, S. Herfst, B. F. Koel, R. A. M. Fouchier
Journal of Virology Apr 2019, 93 (8) e01907-18; DOI: 10.1128/JVI.01907-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antigenic evolution
influenza virus A/H2N2
molecular drift
pandemic

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514